Clinical Trial Update: A Study to Learn About the Safety, Effects and Pharmacokinetics of Study Medication (PF-07054894) for the Treatment of Ulcerative Colitis [Phase 1]

View source ↗

Summary

Phase 1 study to assess safety, pharmacokinetics, and effects of PF-07054894 in ulcerative colitis; the trial was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ulcerative Colitis

Drugs mentioned

• PF-07054894

Snippet

Sponsor: Pfizer | Conditions: Ulcerative Colitis | Phase 1 | Status: TERMINATED